Zephyranthes candida
Zephyranthes candida · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Zephyranthes candida is a remarkable botanical species that has gained significant attention in pharmacological research. Studies focusing on whole plant preparations and n-BuOH extracts have revealed potent biological potential. Specifically, the plant exhibits notable cytostatic and cytotoxic activities against various cellular models. These therapeutic effects are largely attributed to the presence of specialized chemical constituents such as trans-Dihydronarciclasine. Consequently, this species serves as a vital subject for discovering new compounds in cancer research.
- Synonyms
- Atamosco Candida · Zephyranthes Nivea · 4 more
- Common names
- Not available
- Family
- Amaryllidaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Zephyranthes candida is a versatile plant recognized by a diverse array of regional names across the globe. In many English-speaking areas, it is affectionately known as the Autumn Zephyr Lily. Its cultural reach extends into Spanish-speaking regions, where it is frequently called Azucena del río. In Turkey, you might encounter it under the name Beyaz zıpçıktı, while in Indonesia, it is referred to as Kembang Coklat. Finally, in French contexts, this beautiful species is commonly identified as Lis zéphyr.
Sources: Catalogue of Life (COL)
Synonyms
Zephyranthes candida is a botanical subject known by a diverse array of scientific synonyms throughout history. It has been classified under various names, including the designations Amaryllis nivea and Argyropsis candida. Researchers have also identified this species within the genera Atamosco candida and Plectronema candida. Furthermore, the plant is linked to the synonym Hippeastrum zephyranthum in certain taxonomic records. Navigating these shifting botanical labels is essential for anyone studying the complex lineage of this white rain lily.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Zephyranthes candida is a remarkable specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further descends through the order Asparagales, showcasing its unique evolutionary lineage. As a member of the family Amaryllidaceae, it shares structural characteristics with many other striking flowering plants. Ultimately, this species is defined by its placement within the genus Zephyranthes.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Amaryllidaceae |
| Genus | Zephyranthes |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Zephyranthes candida boasts an impressive geographic range that spans across several diverse continents and climates. In Africa, this plant can be found throughout the northern reaches of Tunisia and extending down into the southern Cape Provinces. Its presence is also noted in the subtropical regions of Zimbabwe and the tropical landscapes of the Seychelles in the Western Indian Ocean. Beyond the African continent, the species successfully inhabits the temperate environments of South-Central China. This wide distribution highlights the plant's remarkable ability to adapt to varied ecological niches.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Zephyranthes candida is a self-supporting herb that maintains a sturdy upright structure. This growth form allows the plant to thrive effectively within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Zephyranthes candida has demonstrated significant pharmacological potential through its demonstrated cytostatic and cytotoxic activities. Research indicates that the plant contains specific constituents, such as trans-dihydronarciclasine, which function as potent cytostatic agents against P-388 lymphocytic leukemia cells. Furthermore, various alkaloids isolated from the whole plant have exhibited notable cytotoxicity when tested against several human cancer cell lines. Studies have identified specific compounds, including N-methylhemeanthidine chloride and lycorine, that display effective inhibitory effects in vitro. These findings highlight the plant's importance as a source of bioactive molecules for antineoplastic drug development.
Compounds
Zephyranthes candida serves as a rich source of diverse cytotoxic alkaloids isolated from its whole plant structure. Research has identified several specific compounds within the species, including the known alkaloids 3-epimacronine and hemeanthamin. Furthermore, the plant contains several newly discovered alkaloids such as N-ethoxycarbonylethylcrinasiadine and N-ethoxycarbonylpropylcrinasiadine. The chemical profile is further expanded by the presence of N-isopentylcrinasiadine. These various constituents are of significant interest due to their demonstrated biological activity against several human cancer cell lines.
Conditions
Zephyranthes candida contains bioactive compounds that treat LPS-induced NO production by inhibiting it in RAW264.7 mouse macrophages. This plant also treats P-388 lymphocytic leukemia through the cytostatic action of constituents like trans-dihydronarciclasine. Various isolated alkaloids from the species exhibit acetylcholinesterase inhibitory activities, which are essential for potential neurological applications. Furthermore, Zephyranthes candida treats inflammatory conditions through its significant anti-inflammatory activities. Finally, the plant treats selected human cancer cell lines by inducing apoptosis and cell-cycle arrest in various leukemic cells.
Preparations
Zephyranthes candida is prepared as whole plants to isolate various structurally diverse alkaloids, including zephyranines A-I and 6-O-ethylnerinine. The plant is also prepared as whole plants for the extraction of cytotoxic alkaloids such as N-methylhemeanthidine chloride and lycorine. Additionally, Zephyranthes candida is prepared as whole plants to obtain new flavans that exhibit significant anti-inflammatory effects. Research also shows that Zephyranthes candida is prepared as an n-BuOH extract to identify cytostatic agents like trans-dihydronarciclasine. Finally, the whole plant is utilized to isolate specific chemical constituents, including beta-sitosterol and various stigmasterol derivatives.